186 related articles for article (PubMed ID: 16300908)
1. A new vector for controllable expression of an anti-HER2/neu mini-antibody-barnase fusion protein in HEK 293T cells.
Glinka EM; Edelweiss EF; Sapozhnikov AM; Deyev SM
Gene; 2006 Jan; 366(1):97-103. PubMed ID: 16300908
[TBL] [Abstract][Full Text] [Related]
2. Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells.
Ivanova JL; Edelweiss EF; Leonova OG; Balandin TG; Popenko VI; Deyev SM
Biochimie; 2012 Aug; 94(8):1833-6. PubMed ID: 22531627
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of vaccination with plasmid DNA encoding for HER2/neu or HER2/neu-eGFP fusion protein against prostate cancer in rats.
Bhattachary R; Bukkapatnam R; Prawoko I; Soto J; Morgan M; Salup RR
Int Immunopharmacol; 2002 May; 2(6):783-96. PubMed ID: 12095169
[TBL] [Abstract][Full Text] [Related]
4. Design of multivalent complexes using the barnase*barstar module.
Deyev SM; Waibel R; Lebedenko EN; Schubiger AP; Plückthun A
Nat Biotechnol; 2003 Dec; 21(12):1486-92. PubMed ID: 14634668
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy for regulated expression of a cytotoxic gene.
Bi YM; Rothstein SJ; Wildeman AG
Gene; 2001 Nov; 279(2):175-9. PubMed ID: 11733142
[TBL] [Abstract][Full Text] [Related]
6. [Targeted detecting HER2 expression with recombinant anti HER2 ScFv-GFP fusion antibody].
Gao G; Chen C; Yang Y; Yang H; Wang J; Zheng Y; Huang Q; Hu X
Sheng Wu Gong Cheng Xue Bao; 2012 Aug; 28(8):1002-14. PubMed ID: 23185900
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.
Balandin TG; Edelweiss E; Andronova NV; Treshalina EM; Sapozhnikov AM; Deyev SM
Invest New Drugs; 2011 Feb; 29(1):22-32. PubMed ID: 19789841
[TBL] [Abstract][Full Text] [Related]
8. [Immunocytochemical visualization of P185(HER2) receptor by antibody fused with dibarnase and conjugate of barstar with colloidal gold].
Ivanova IuL; Edelweiss EF; Leonova OG; Balandin TG; Popenko VI; Deev SM
Mol Biol (Mosk); 2013; 47(5):806-17. PubMed ID: 25509353
[TBL] [Abstract][Full Text] [Related]
9. Barnase as a new therapeutic agent triggering apoptosis in human cancer cells.
Edelweiss E; Balandin TG; Ivanova JL; Lutsenko GV; Leonova OG; Popenko VI; Sapozhnikov AM; Deyev SM
PLoS One; 2008 Jun; 3(6):e2434. PubMed ID: 18560598
[TBL] [Abstract][Full Text] [Related]
10. Construction of the plasmid for expression of ETA-EGFP fusion protein under control of the cytomegalovirus promoter and its effects in HeLa cells.
Glinka EM; Andryushchenko AS; Sapozhnikov AM; Zatsepina OV
Plasmid; 2009 Sep; 62(2):119-27. PubMed ID: 19527753
[TBL] [Abstract][Full Text] [Related]
11. [Construction of expression vector for human-mouse chimeric antibody and expression of an antibody against human HER2].
Wang LL; Han H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):363-5. PubMed ID: 15193240
[TBL] [Abstract][Full Text] [Related]
12. Conditional cell ablation by stringent tetracycline-dependent regulation of barnase in mammalian cells.
Leuchtenberger S; Perz A; Gatz C; Bartsch JW
Nucleic Acids Res; 2001 Aug; 29(16):E76. PubMed ID: 11504884
[TBL] [Abstract][Full Text] [Related]
13. Construction and use of retroviral vectors encoding the toxic gene barnase.
Agarwal S; Nikolai B; Yamaguchi T; Lech P; Somia NV
Mol Ther; 2006 Oct; 14(4):555-63. PubMed ID: 16814610
[TBL] [Abstract][Full Text] [Related]
14. Expression of single-chain antibody-barstar fusion in plants.
Semenyuk EG; Stremovskiy OA; Edelweiss EF; Shirshikova OV; Balandin TG; Buryanov YI; Deyev SM
Biochimie; 2007 Jan; 89(1):31-8. PubMed ID: 16938381
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors.
Helguera G; Dela Cruz JS; Lowe C; Ng PP; Trinh R; Morrison SL; Penichet ML
Vaccine; 2006 Jan; 24(3):304-16. PubMed ID: 16125282
[TBL] [Abstract][Full Text] [Related]
16. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
Li X; Stuckert P; Bosch I; Marks JD; Marasco WA
Cancer Gene Ther; 2001 Aug; 8(8):555-65. PubMed ID: 11571533
[TBL] [Abstract][Full Text] [Related]
17. [Eukaryotic expression and biological activities of anti-p185 erbB2 mouse/human chimeric antibody].
Jiang BH; Liu WB; Meng L; Wu J; Shou CC
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):491-5. PubMed ID: 15489929
[TBL] [Abstract][Full Text] [Related]
18. [Construction of eukaryotic expression vector for EBF3 and EGFP fusion protein and its expression in HepG2 cells].
Mao LP; Wang HM; Wang YG; Wang XY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):954-7. PubMed ID: 18845077
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of eukaryotic cell expression of wild-type and Pro370Leu mutation type myocilin gene].
Wang JW; Sun HM; Ji J; Li XR; Zheng JQ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):700-4. PubMed ID: 16681932
[TBL] [Abstract][Full Text] [Related]
20. Heterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells.
Spång HC; Braathen R; Bogen B
PLoS One; 2012; 7(9):e45393. PubMed ID: 23028981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
